These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1401 related articles for article (PubMed ID: 33692201)

  • 1. Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    Jacob-Dolan C; Feldman J; McMahan K; Yu J; Zahn R; Wegmann F; Schuitemaker H; Schmidt AG; Barouch DH
    J Virol; 2021 May; 95(11):. PubMed ID: 33692201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2.
    Galipeau Y; Siragam V; Laroche G; Marion E; Greig M; McGuinty M; Booth RA; Durocher Y; Cuperlovic-Culf M; Bennett SAL; Crawley AM; Giguère PM; Cooper C; Langlois MA
    EBioMedicine; 2021 Dec; 74():103700. PubMed ID: 34861490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
    Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals.
    Longet S; Hargreaves A; Healy S; Brown R; Hornsby HR; Meardon N; Tipton T; Barnes E; Dunachie S; Duncan CJA; Klenerman P; Richter A; Turtle L; de Silva TI; Carroll MW
    Front Immunol; 2022; 13():953949. PubMed ID: 36159846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs.
    Liu Z; Zhou J; Xu W; Deng W; Wang Y; Wang M; Wang Q; Hsieh M; Dong J; Wang X; Huang W; Xing L; He M; Tao C; Xie Y; Zhang Y; Wang Y; Zhao J; Yuan Z; Qin C; Jiang S; Lu L
    Cell Res; 2022 Mar; 32(3):269-287. PubMed ID: 35046518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
    Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
    Mercado NB; Zahn R; Wegmann F; Loos C; Chandrashekar A; Yu J; Liu J; Peter L; McMahan K; Tostanoski LH; He X; Martinez DR; Rutten L; Bos R; van Manen D; Vellinga J; Custers J; Langedijk JP; Kwaks T; Bakkers MJG; Zuijdgeest D; Rosendahl Huber SK; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Hoffman E; Jacob-Dolan C; Kirilova M; Li Z; Lin Z; Mahrokhian SH; Maxfield LF; Nampanya F; Nityanandam R; Nkolola JP; Patel S; Ventura JD; Verrington K; Wan H; Pessaint L; Van Ry A; Blade K; Strasbaugh A; Cabus M; Brown R; Cook A; Zouantchangadou S; Teow E; Andersen H; Lewis MG; Cai Y; Chen B; Schmidt AG; Reeves RK; Baric RS; Lauffenburger DA; Alter G; Stoffels P; Mammen M; Van Hoof J; Schuitemaker H; Barouch DH
    Nature; 2020 Oct; 586(7830):583-588. PubMed ID: 32731257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
    He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van Heerden M; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
    Cell; 2021 Jun; 184(13):3467-3473.e11. PubMed ID: 34133941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    Liu MQ; Jiang RD; Guo J; Chen Y; Yang DS; Wang X; Lin HF; Li A; Li B; Hu B; Wang ZJ; Yang XL; Shi ZL
    J Virol; 2022 Apr; 96(8):e0016922. PubMed ID: 35343762
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 71.